Yoshikawa, Ken Tsuchiya, Akira Kido, Tomoyuki Ota, Tomohiro Ikeda, Keiko Iwakura, Mika Maeda, Yoshikazu Maekawa, Shinichiroh Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study <p></p><p>The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC. 2020.<b> </b></p><br><p></p> Efficacy;Observational study;Post-marketing surveillance;Safety;Sitagliptin;Type 2 diabetes mellitus 2020-03-31
    https://adisjournals.figshare.com/articles/figure/Long-Term_Safety_and_Efficacy_of_Sitagliptin_for_Type_2_Diabetes_Mellitus_in_Japan_Results_of_a_Multicentre_Open-Label_Observational_Post-Marketing_Surveillance_Study/11961306
10.6084/m9.figshare.11961306.v1